作者: Federico Moscardó , Francisca Pérez , Javier De La Rubia , Begoña Balerdi , José I. Lorenzo
DOI: 10.1046/J.1365-2141.2001.02878.X
关键词:
摘要: Recombinant activated factor VII (rFVIIa) is indicated mainly for the treatment of patients with haemophilia and inhibitors. However, little information is available on the use of rFVIIa in …